Top Markets
Coin of the day
Genex Pharmaceutical, Inc. Genex Pharmaceutical, Inc.

Genex Pharmaceutical, Inc.

GENX
Rank in Stocks #42367
Genex Pharmaceutical, Inc. engages in the development and production of... Genex Pharmaceutical, Inc. engages in the development and production of Reconstituted Bone Xenograft, which is a medical device that accelerates bone healing. The company was founded on February 28, 2002 and is headquartered in Tianjin, China.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$1.79K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
CN
Trade Genex Pharmaceutical, Inc. (GENX)

Category

P/B ratio for Genex Pharmaceutical, Inc. (GENX)
P/B ratio as of 2026 TTM: 0
According to Genex Pharmaceutical, Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Genex Pharmaceutical, Inc. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors